|1.||Brennan, Marie-Luise: 2 articles (08/2004 - 10/2002)|
|2.||Nishikawa, Akiyoshi: 1 article (09/2009)|
|3.||Umemura, Takashi: 1 article (09/2009)|
|4.||Okamura, Toshiya: 1 article (09/2009)|
|5.||Tasaki, Masako: 1 article (09/2009)|
|6.||Ishii, Yuji: 1 article (09/2009)|
|7.||Inoue, Tomoki: 1 article (09/2009)|
|8.||Savaş, Berna: 1 article (11/2007)|
|9.||Ciftcioglu, Akif: 1 article (11/2007)|
|10.||Akar, Yusuf: 1 article (11/2007)|
09/19/2009 - "Precise quantitative analysis of NO(2)Tyr by means of liquid chromatography with tandem mass spectrometry (LC-MS/MS) in an additional study with the same experimental protocol confirmed increase of RNS due to the reaction of catechol with NO produced after APAP-induced hepatitis. "
09/19/2009 - "Along with several indicators of APAP-induced hepatitis, 8-hydroxydeoxyguanosine (8-OHdG) levels and immunohistochemistry for 3-nitrotyrosine (NO(2)Tyr) in the livers were examined at 1.5, 4 and 24h after APAP injection. "
|4.||Coronary Artery Disease (Coronary Atherosclerosis)
10/01/2002 - "Coronary arteries from a patient with coronary artery disease, liver and lung tissues from a sickle cell disease patient, and an open lung biopsy from a lung transplant patient undergoing rejection were analyzed immunohistochemically to map relative tissue distributions of MPO and NO(2)Tyr. "
|5.||Cardiovascular Diseases (Cardiovascular Disease)
08/01/2004 - "Dramatic selective enrichment in NO(2)Tyr and chlorotyrosine (ClTyr) content within apoA-I recovered from serum and human atherosclerotic lesions is noted, and analysis of serum from sequential subjects demonstrates that the NO(2)Tyr and ClTyr contents of apoA-I are markedly higher in individuals with cardiovascular disease (CVD). "
|4.||Apolipoprotein A-I (Apolipoprotein A1)